These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 25787055)

  • 1. Epstein-Barr virus candidate genes and multiple sclerosis.
    Claire Simon K; Schmidt H; Loud S; Ascherio A
    Mult Scler Relat Disord; 2015 Jan; 4(1):60-4. PubMed ID: 25787055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Huang J; Tengvall K; Lima IB; Hedström AK; Butt J; Brenner N; Gyllenberg A; Stridh P; Khademi M; Ernberg I; Al Nimer F; Manouchehrinia A; Hillert J; Alfredsson L; Andersen O; Sundström P; Waterboer T; Olsson T; Kockum I
    Brain; 2024 Oct; 147(10):3573-3582. PubMed ID: 38630618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
    Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
    Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.
    Simon KC; Schmidt H; Loud S; Ascherio A
    Mult Scler; 2015 May; 21(6):703-9. PubMed ID: 25305254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strains of Epstein-Barr virus infecting multiple sclerosis patients.
    Brennan RM; Burrows JM; Bell MJ; Bromham L; Csurhes PA; Lenarczyk A; Sverndal J; Klintenstedt J; Pender MP; Burrows SR
    Mult Scler; 2010 Jun; 16(6):643-51. PubMed ID: 20350958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis.
    Mueller NE; Lennette ET; Dupnik K; Birmann BM
    Int J Cancer; 2012 Jun; 130(12):2886-91. PubMed ID: 21805472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.
    Tengvall K; Huang J; Hellström C; Kammer P; Biström M; Ayoglu B; Lima Bomfim I; Stridh P; Butt J; Brenner N; Michel A; Lundberg K; Padyukov L; Lundberg IE; Svenungsson E; Ernberg I; Olafsson S; Dilthey AT; Hillert J; Alfredsson L; Sundström P; Nilsson P; Waterboer T; Olsson T; Kockum I
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16955-16960. PubMed ID: 31375628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
    PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
    Lucas RM; Ponsonby AL; Dear K; Valery P; Pender MP; Burrows JM; Burrows SR; Chapman C; Coulthard A; Dwyer DE; Dwyer T; Kilpatrick T; Lay ML; McMichael AJ; Taylor BV; van der Mei IA; Williams D
    Neurology; 2011 Jul; 77(4):371-9. PubMed ID: 21753179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
    Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
    PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
    Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
    Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age at Epstein-Barr virus infection and Epstein-Barr virus nuclear antigen-1 antibodies in Swedish children.
    Simon KC; Saghafian-Hedengren S; Sverremark-Ekström E; Nilsson C; Ascherio A
    Mult Scler Relat Disord; 2012 Jul; 1(3):136-8. PubMed ID: 25877079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis?
    Mameli G; Madeddu G; Cossu D; Galleri G; Manetti R; Babudieri S; Mura MS; Sechi LA
    Eur J Neurol; 2016 Jan; 23(1):140-7. PubMed ID: 26453465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
    Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
    DeLorenze GN; Munger KL; Lennette ET; Orentreich N; Vogelman JH; Ascherio A
    Arch Neurol; 2006 Jun; 63(6):839-44. PubMed ID: 16606758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBNA1 and LMP1 variants in multiple sclerosis cases and controls.
    Simon KC; Yang X; Munger KL; Ascherio A
    Acta Neurol Scand; 2011 Jul; 124(1):53-8. PubMed ID: 20636447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
    Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
    J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus in multiple sclerosis.
    Abdelrahman HS; Selim HS; Hashish MH; Sultan LI
    J Egypt Public Health Assoc; 2014 Aug; 89(2):90-5. PubMed ID: 25162741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
    Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.